VTRS | tickerfilter.com

Fundamental analysis

36%

Profitability 36%

Dept financing 40%

Liquidity 54%

Performance 30%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-0.27%

1 Month

3.69%

3 Months

38.38%

6 Months

44.14%

1 Year

58.91%

2 Year

20.47%

Key data

Stock price

$14.89

P/E Ratio

0.00

DAY RANGE

$14.72 - $15.23

EPS

-$3.44

52 WEEK RANGE

$6.85 - $16.47

52 WEEK CHANGE

$57.07

MARKET CAP

14.340 B

YIELD

3.86%

SHARES OUTSTANDING

1.151 B

DIVIDEND

$0.12

EX-DIVIDEND DATE

03-09-2026

NEXT EARNINGS DATE

08-07-2025

BETA

0.58

PUBLIC FLOAT

AVERAGE 10 VOLUME

$14,706,488

AVERAGE 30 VOLUME

$12,138,778

Company detail

CEO: Michael Goettler
Region: US
Website: viatris.com
Employees: 37,000
IPO year: 1987

Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Viatris Inc. operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology. It distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies.

VTRS - Viatris Inc